Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
There is evidence that up to 30% of COVID-19 patients was reported with neurological manifestations such as impaired consciousness, headache, and dizziness have been reported in COVID-19 patients in addition, olfactory and taste alterations are common symptoms in patients affected by COVID-19.This study will be conducted to evaluate the effect of the novel coronavirus on audio-vestibular functions in confirmed COVID19 patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Basic audiological evaluation: | Pure-tone audiometry. | 3 months after infection |
| Basic audiological evaluation: | Acoustic immittance testing | 3 months after infection |
| Basic audiological evaluation: | Speech audiometry | 3 months after infection |
| Auditory evoked potentials: | Auditory brainstem response. | 3 months after infection |
| Auditory evoked potentials | P300 | 3 months after infection |
| Effect on vestibular functions | Videonystagmography | 3 months after infection |
| Effect on vestibular functions | Video Head Implus test VHIT. | 3 months after infection |
| Effect on vestibular functions | Vestibular evoked myogenic potential. | 3 months after infection |
| Effect on vestibular functions |
| Measure | Description | Time Frame |
|---|---|---|
| Effect on cognitive functions | Cognitive function assessment: By Montreal test | 3 months after infection |
| Vestibular questionnaire | Dizziness Handicap Inventory (DHI). |
Not provided
Inclusion Criteria:
- Well educated patients Age: range between 20 to 50 years No previous history of hearing loss or otoneurologic disease
Well confirmed COVID 19 patients:
patients who were diagnosed with coronavirus from
Exclusion Criteria:
Not provided
Not provided
The present study will include 100 of randomly selected patients who were had been confirmed to be infection with COVID 19 virus, age ranged from 20-50 years. The investigation will be done three months after infection and after being sure that the patient become noninfectious.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yasmeen Mohamed | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sohag faculty of medicine | Sohag | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Dec 8, 2024 | |
| Reset | Jan 24, 2025 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Dec 8, 2024 | Jan 24, 2025 |
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Computerized Dynamic Posturography (CDP)
| 3 months after infection |
| 3 months after infection |
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |